Kamran Ahmed, MD

H. Lee Moffitt Cancer Center

Tampa, FL

Dr. Kamran Ahmed is an Associate Member with Tenure in the Department of Radiation Oncology and Department of Immunology at Moffitt Cancer Center and an Associate Professor in the Department of Oncologic Sciences at the University of South Florida. He is the Vice Chair for Clinical Research in the Department of Radiation Oncology and the Section Chief for the Breast Radiotherapy Service at Moffitt Cancer Center. He is also the Program Director for the Advanced Radiation Oncology Research Fellowship. Dr. Ahmed received his medical degree from the Mayo Clinic Alix School of Medicine in Rochester, MN and completed an internship at Baylor College of Medicine before completing his radiation oncology residency at Moffitt Cancer Center. His clinical focus is the management of patients with breast cancer. Dr. Ahmed’s primary research interest is in studying the synergism between combinations of immunologic and targeted agents with radiation therapy to improve clinical outcomes. He is the principal investigator of several multicenter clinical trials in the management of brain metastases and leptomeningeal disease with novel therapeutics and radiation therapy. He is also interested in studying personalized radiation delivery through genomic and radiomic approaches to tailor therapy to the patient. He serves on multiple journal editorial boards. Dr. Ahmed has published over 100 peer-reviewed manuscripts and has presented his research nationally and internationally.

Disclosures:

Employment: Moffitt Cancer Center:Associate Member:Employee
Compensation: Bristol Myers-Squibb: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present ;Eli Lilly: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present ;Genentech: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present ;Gilead: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: Present ;Castle Biosciences: Advisory Board, Advi
Ownership: none
Leadership: Advances in Radiation Oncology:Editorial Board;Neuro-Oncology Practice:Editorial Board Member;ABR:Committee Member;Journal of Neuro-Oncology:Editorial Board Member;American Journal of Clinical Oncology:Editorial Board Member